JXJin Xu

Jin Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jin Xu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Haiqing Zhang

    Department of Endocrinology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, 250021, People’s Republic of China

    2 shared publications
  • Jiajun Zhao

    Shandong Provincial Hospital Affiliated to Shandong First Medical University

    2 shared publications
  • Meng Zhao

    Department of Endocrinology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China

    2 shared publications
  • Bingchang Zhang

    Department of Neurosurgery and Department of Neuroscience, Fujian Key Laboratory of Brain Tumors Diagnosis and Precision Treatment, Xiamen Key Laboratory of Brain Center, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

    1 shared publication
  • Dongmei Zheng

    Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, 250021, China

    1 shared publication
  • Ling Gao

    Shandong Clinical Medical Center of Endocrinology and Metabolism, Institute of Endocrinology and Metabolism, Shandong Academy of Clinical Medicine, 250021, China

    1 shared publication

Latest Publications

  • Open Access

    Different Contributions of Dyslipidemia and Obesity to the Natural History of Type 2 Diabetes: 3-Year Cohort Study in China

    by Lu Liu, Xiaoling Guan, Zhongshang Yuan, Meng Zhao, Qiu Li, Xu Zhang, Haiqing Zhang, Dongmei Zheng, Jin Xu, Ling Gao, et al.

    Aim. It is known that different stages of type 2 diabetes represent distinct pathophysiological changes, but how the spectrum of risk factors varies at different stages is not yet clarified. Hence, the aim of this study was to compare the effect of different metabolic variables on the natural history of type 2 diabetes. Methods. A total of 5,213 nondiabetic (normal glucose tolerance (NGT) and prediabetes) Chinese older than 40 years participated this prospective cohort study, and 4,577 completed the 3-year follow-up. Glycemic status was determined by standard oral glucose tolerance test both at enrollment and follow-up visit. Predictors for conversion in glycemic status were studied in a corresponding subcohort using the multiple logistic regression analysis. Results. The incidence of prediabetes and diabetes of the cohort was 93.6 and 42.2 per 1,000 person-years, respectively. After a 3-year follow-up, 33.1% of prediabetes patients regressed to NGT. The predictive weight of body mass index (BMI), serum triglyceride, total cholesterol, and systolic blood pressure in different paths of conversions among diabetes, prediabetes, and NGT differed. Specifically, BMI was the strongest predictor for regression from prediabetes to NGT, while triglyceride was most prominent for onset of diabetes. One SD increase in serum triglyceride was associated with a 1.29- (95% CI 1.10–1.52; P=0.002) or 1.12- (95% CI 1.01–1.27; P=0.039) fold higher risk of diabetes for individuals with NGT or prediabetes, respectively. Conclusion. Risk factors for different stages of diabetes differed, suggesting personalized preventive strategies for individuals with different basal glycemic statuses.


  • Open Access

    Thyroxine therapy ameliorates serum levels of eicosanoids in Chinese subclinical hypothyroidism patients

    by Yan Zhang, Bing-Chang Zhang, Jin Xu, Meng Zhao, Zhe Wang, Yong-Feng Song, Hai-Qing Zhang, Ling Gao, Qun-Ye Zhang, Jia-Jun Zhao

    APS (Acta Pharmacologica Sinica), the top pharmacology research journal based in China, publishes original articles and reviews on all aspects of pharmacology and the related life sciences